Chronic Fatigue Syndrome (ME/CFS)
Summary
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, chronic, multisystem disease characterised by profound fatigue lasting at least 6 months, post-exertional malaise (PEM), unrefreshing sleep, and cognitive dysfunction ("brain fog"). It is a diagnosis of exclusion — all other causes of fatigue must be ruled out. ME/CFS can be severely disabling, with 25% of patients housebound or bedbound. The 2021 NICE guideline NG206 represented a paradigm shift: it removed graded exercise therapy (GET) as a treatment and emphasised energy management (pacing) as the core approach. There is no cure, and management focuses on symptom control, pacing within the "energy envelope," and multidisciplinary support.
Key Facts
- Definition: Chronic fatigue ≥6 months + PEM + unrefreshing sleep + cognitive difficulties
- Post-exertional malaise (PEM): Hallmark feature — worsening of symptoms after physical or cognitive exertion
- Prevalence: ~0.2-0.4% of the population; affects all ages
- Sex ratio: Female predominance (3-4:1)
- Triggers: Often follows viral infection (EBV, COVID-19) but cause unknown
- Severity: Mild (mobile, can work with difficulty) to severe (housebound/bedbound)
- NICE 2021: GET removed; energy management (pacing) is now the key strategy
- No biomarker: Diagnosis is clinical; exclude other causes
- Prognosis: Variable; many remain symptomatic for years; children have better outcomes
Clinical Pearls
"PEM Is the Cardinal Feature": Post-exertional malaise — a delayed worsening of symptoms 24-72 hours after even minor exertion — is what distinguishes ME/CFS from other fatigue conditions. Always ask about it.
"GET Is No Longer Recommended": The 2021 NICE guideline (NG206) removed graded exercise therapy as a treatment. Pushing through symptoms often causes harm. Energy management (pacing) is now emphasised.
"It's a Diagnosis of Exclusion": You must exclude organic causes before diagnosing ME/CFS: hypothyroidism, diabetes, anaemia, coeliac disease, sleep apnoea, depression, malignancy.
"The Energy Envelope": Patients should identify their energy limits and stay within them ("pacing"). Boom-bust cycles (overdoing it on good days) worsen PEM.
"Long COVID Overlap": Many patients with post-COVID syndrome have symptoms indistinguishable from ME/CFS. The same management principles apply.
Why This Matters Clinically
ME/CFS is often misunderstood and under-recognised. Patients frequently experience diagnostic delays of years and may face dismissive attitudes. Understanding the updated NICE guidance is essential — inappropriate advice to "push through" can cause significant harm. Compassionate, patient-centred care and evidence-based energy management can substantially improve quality of life.[1,2]
Incidence & Prevalence
| Parameter | Data |
|---|---|
| Prevalence | 0.2-0.4% of population (~250,000 in UK) |
| Incidence | ~1-2 per 1,000 person-years |
| Peak onset age | 20-40 years (but can occur at any age) |
| Childhood ME/CFS | Significant burden; often better prognosis |
Demographics
| Factor | Details |
|---|---|
| Sex | Female:Male = 3-4:1 |
| Ethnicity | Affects all ethnic groups |
| Socioeconomic | All socioeconomic groups; may be underdiagnosed in certain communities |
Risk Factors
| Factor | Notes |
|---|---|
| Viral infection | EBV (glandular fever), COVID-19, influenza — common triggers |
| Female sex | Higher prevalence |
| Family history | Some familial clustering |
| Immune dysfunction | May be relevant (speculative) |
| Stressful life events | Sometimes precede onset |
Current Understanding
The exact cause of ME/CFS is unknown. It is likely a heterogeneous condition with multiple contributing factors. Key hypotheses include:
Immune Dysregulation:
- Altered cytokine profiles
- Reduced NK cell function
- Chronic low-grade inflammation
- Autoimmune phenomena suggested by some studies
Autonomic Dysfunction:
- Orthostatic intolerance common (POTS, orthostatic hypotension)
- Abnormal heart rate variability
- Suggests dysautonomia
Mitochondrial Dysfunction:
- Impaired cellular energy production suggested
- Explains exercise intolerance and PEM
- Evidence mixed
Central Nervous System Effects:
- Neuroinflammation suggested by some PET studies
- Altered brain connectivity
- Cognitive symptoms ("brain fog")
Post-Infectious Trigger:
- Many cases follow viral illness (EBV, COVID-19, enteroviruses)
- Abnormal immune response may perpetuate symptoms
- "Hit and run" hypothesis — virus triggers but may not persist
Post-Exertional Malaise (PEM)
| Feature | Details |
|---|---|
| Definition | Worsening of symptoms following physical, cognitive, or emotional exertion |
| Timing | Onset 12-72 hours after activity |
| Duration | Hours to days; can be prolonged |
| Severity | Can be debilitating — patients describe "crash" or "payback" |
| Key to diagnosis | PEM distinguishes ME/CFS from other causes of chronic fatigue |
Core Symptoms (NICE NG206 Criteria)
All four must be present for ≥3 months (suspected) or ≥6 months (confirmed):
| Symptom | Description |
|---|---|
| Debilitating fatigue | Profound, not explained by exertion, not relieved by rest |
| Post-exertional malaise (PEM) | Symptom worsening after activity; delayed onset; prolonged recovery |
| Unrefreshing sleep | Sleep does not restore energy |
| Cognitive difficulties | "Brain fog" — poor concentration, word-finding, memory |
Additional Common Symptoms
| Symptom | Notes |
|---|---|
| Orthostatic intolerance | Dizziness on standing; POTS; presyncope |
| Pain | Muscle pain, joint pain, headaches |
| Flu-like symptoms | Sore throat, tender lymph nodes |
| Sensitivity to light, sound, temperature | Sensory overload |
| Sleep disturbance | Insomnia, hypersomnia, reversed sleep cycle |
| GI symptoms | IBS-like features common |
Severity Classification
| Severity | Description |
|---|---|
| Mild | Can perform light activities; often can work (with difficulty); reduced social activities |
| Moderate | Reduced mobility; unable to work; needs rest periods; house-bound at times |
| Severe | Housebound; wheelchair-dependent; significant ADL limitations |
| Very severe | Bedbound; totally dependent for care; often unable to tolerate light/sound |
Red Flags (Consider Alternative Diagnosis)
[!CAUTION] Red Flags — Investigate for Organic Causes:
- Unexplained weight loss
- Focal neurological signs
- Significant lymphadenopathy or hepatosplenomegaly
- Persistently elevated inflammatory markers or ESR
- Fevers of unknown origin
- New symptoms not fitting ME/CFS pattern
- Symptoms entirely explained by psychiatric illness
Approach
Examination in ME/CFS is often unremarkable but is essential to exclude other conditions.
General:
- Appears fatigued
- May appear well at rest (symptoms fluctuate)
- Pallor (exclude anaemia)
- Signs of thyroid dysfunction
Cardiovascular:
- Orthostatic vital signs (lying → standing BP/HR)
- POTS: HR increase ≥30 bpm within 10 minutes of standing (without BP drop)
- Orthostatic hypotension: BP drop ≥20/10 mmHg
Neurological:
- Usually normal
- Exclude focal signs (would suggest alternative diagnosis)
Lymph nodes:
- May have mild tenderness (common in ME/CFS)
- Significant lymphadenopathy = investigate
Musculoskeletal:
- Tenderness without swelling common
- Exclude inflammatory arthritis
Tests for Orthostatic Intolerance
| Test | Technique | Positive Finding |
|---|---|---|
| NASA Lean Test | Lean against wall, feet 6 inches out; 10 min | HR ≥30 bpm increase; symptoms |
| Active Stand Test | BP/HR lying; then standing at 0, 2, 5, 10 min | POTS or orthostatic hypotension |
| Tilt Table Test | Formal testing if needed | POTS, vasovagal, orthostatic hypotension |
Purpose of Investigations
Investigations are to exclude other causes of fatigue, not to confirm ME/CFS (there is no diagnostic test).
First-Line Investigations
| Investigation | Purpose / Exclusion |
|---|---|
| FBC | Anaemia, malignancy |
| U&E, Creatinine | Renal disease |
| LFTs | Liver disease |
| TFTs | Hypothyroidism, hyperthyroidism |
| Glucose / HbA1c | Diabetes |
| CRP / ESR | Inflammatory conditions |
| Coeliac serology | Coeliac disease (common mimic) |
| Vitamin D | Deficiency common |
| Ferritin | Iron deficiency (with or without anaemia) |
| Urinalysis | Diabetes, infection, renal disease |
Additional Tests (As Indicated)
| Investigation | Indication |
|---|---|
| Cortisol (9am) | Adrenal insufficiency |
| B12, Folate | Deficiency |
| Calcium | Hypercalcaemia |
| HIV, Hepatitis B/C | If risk factors |
| ANA, RF | If autoimmune features |
| Sleep study | If sleep apnoea suspected |
| MRI Brain | If neurological symptoms/signs |
What NOT to Order
- Extensive "fishing" panels are not recommended
- ME/CFS does not have a diagnostic biomarker
- Avoid unnecessary invasive tests
Management Algorithm
ME/CFS MANAGEMENT (NICE NG206)
↓
┌─────────────────────────────────────────────────────────────┐
│ DIAGNOSIS │
├─────────────────────────────────────────────────────────────┤
│ ➤ Clinical criteria: Fatigue + PEM + Unrefreshing sleep │
│ + Cognitive dysfunction (≥6 months) │
│ ➤ Exclude differential diagnoses (investigations above) │
│ ➤ If 3-6 months symptoms: "Suspected ME/CFS" │
│ ➤ If ≥6 months: "Confirmed ME/CFS" │
└─────────────────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────────────────┐
│ CORE MANAGEMENT: ENERGY MANAGEMENT (PACING) │
├─────────────────────────────────────────────────────────────┤
│ ➤ Identify "Energy Envelope" — limits of physical, │
│ cognitive, emotional activity │
│ ➤ Plan activities to stay within envelope │
│ ➤ Avoid "boom-bust" pattern │
│ ➤ Include rest breaks │
│ ➤ Prioritise activities │
│ ➤ Adjust for fluctuations │
│ │
│ ❌ DO NOT OFFER: │
│ • Graded Exercise Therapy (GET) as treatment │
│ • Programmes based on fixed incremental activity │
│ • Lightning Process or similar therapies │
└─────────────────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────────────────┐
│ SYMPTOM MANAGEMENT │
├─────────────────────────────────────────────────────────────┤
│ SLEEP DISTURBANCE: │
│ ➤ Sleep hygiene advice │
│ ➤ Low-dose amitriptyline (10-25 mg nocte) if needed │
│ ➤ Avoid stimulants │
│ │
│ PAIN: │
│ ➤ Simple analgesia (paracetamol) │
│ ➤ Low-dose amitriptyline for neuropathic pain │
│ ➤ Avoid opioids if possible │
│ │
│ ORTHOSTATIC INTOLERANCE: │
│ ➤ Increase salt and fluid intake │
│ ➤ Compression stockings │
│ ➤ If POTS: Consider fludrocortisone, midodrine (specialist)│
│ │
│ COGNITIVE DYSFUNCTION: │
│ ➤ Pacing cognitive activity │
│ ➤ Memory aids, lists, routines │
└─────────────────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────────────────┐
│ MULTIDISCIPLINARY SUPPORT │
├─────────────────────────────────────────────────────────────┤
│ ➤ Access to specialist ME/CFS service if available │
│ ➤ Occupational therapy (for ADLs, aids) │
│ ➤ Physiotherapy (gentle movement within limits) │
│ ➤ Psychology (for adjustment, not as cure) │
│ ➤ Social care and benefits advice │
│ ➤ Support groups (ME Association, Action for ME) │
└─────────────────────────────────────────────────────────────┘
Key Management Principles (NICE NG206)
| Principle | Details |
|---|---|
| Energy Management (Pacing) | Core strategy; stay within energy envelope |
| Personalised approach | Tailor to individual severity and preferences |
| Avoid harm | Do NOT recommend GET, "pushing through," or fixed activity programmes |
| Symptom relief | Treat pain, sleep, orthostatic symptoms |
| Multidisciplinary | Access to specialist services if available |
| Regular review | Monitor for deterioration, adjustment of plan |
Disease-Related Complications
| Complication | Description |
|---|---|
| Severe functional disability | 25% housebound or bedbound |
| Social isolation | Inability to maintain relationships, work |
| Loss of employment | Significant financial and psychological impact |
| Mental health comorbidity | Depression, anxiety (secondary to chronic illness) |
| Deconditioning | Due to prolonged inactivity (requires careful management) |
Iatrogenic Harm
| Issue | Notes |
|---|---|
| Harm from GET | Pushing beyond limits worsens PEM; now removed from NICE |
| Dismissal and disbelief | Psychological harm from not being believed |
| Delay in diagnosis | Average diagnostic delay = 4-5 years |
Natural History
| Outcome | Proportion |
|---|---|
| Full recovery | 5-10% (higher in children/young people) |
| Significant improvement | 10-20% |
| Fluctuating course | Most common — better and worse periods |
| Stable chronic illness | Common |
| Progressive deterioration | Minority; especially if repeatedly overexerting |
Prognostic Factors
| Good Prognosis | Poor Prognosis |
|---|---|
| Younger age at onset | Older age |
| Shorter illness duration at diagnosis | Long delay to diagnosis |
| Milder severity | Severe/very severe at baseline |
| Childhood onset | Onset in adulthood |
| Early access to pacing/support | Repeated "push-crash" cycles |
Key Guidelines
| Guideline | Organisation | Year | Key Points |
|---|---|---|---|
| ME/CFS: Diagnosis and Management (NG206) | NICE | 2021 | Paradigm shift; removed GET; energy management central |
| IOM Report | Institute of Medicine (USA) | 2015 | Renamed "Systemic Exertion Intolerance Disease"; diagnostic criteria |
Key Changes in NICE NG206 (2021)
| Previous Recommendation | Current Recommendation (2021) |
|---|---|
| Graded Exercise Therapy (GET) | Removed — no longer recommended |
| CBT as treatment | CBT only for managing impact of illness, NOT as cure |
| Lightning Process | Not recommended |
| PACE Trial as evidence | Criticised; not used as basis for recommendations |
PACE Trial Controversy
| Issue | Details |
|---|---|
| Original claims | GET and CBT effective for ME/CFS |
| Criticism | Methodological issues; subjective outcomes; re-analysis showed weaker results |
| Current status | NICE 2021 rejected GET; patient advocacy highlighted concerns |
| Lesson | Importance of patient involvement; questioning trial design |
What is ME/CFS?
ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) is a long-term illness that causes extreme tiredness, problems with sleep, difficulty thinking clearly ("brain fog"), and something called post-exertional malaise (PEM) — where symptoms get worse after even small amounts of activity.
What causes it?
The exact cause isn't known. It often starts after a viral infection (like glandular fever or COVID-19). Researchers think it may involve the immune system and how the body produces energy.
How is it diagnosed?
There is no specific test for ME/CFS. Doctors diagnose it based on your symptoms — mainly tiredness lasting at least 6 months, post-exertional malaise, unrefreshing sleep, and brain fog — and by ruling out other conditions.
How is it treated?
There is no cure, but there are things that help:
- Energy management (pacing): Learning your limits and staying within them. This is the most important strategy.
- Rest: Allow yourself proper rest periods.
- Symptom treatment: Medicines can help with sleep and pain.
- Support: Occupational therapy, support groups, and sometimes specialist ME/CFS clinics.
Important: "Pushing through" or forcing yourself to exercise more does NOT help and can make things worse.
What to avoid
- Don't try to "fight through" the fatigue
- Avoid boom-bust cycles (overdoing it on good days)
- Graded exercise therapy (GET) is no longer recommended
Where to get support
- ME Association: meassociation.org.uk
- Action for ME: actionforme.org.uk
- NHS ME/CFS services (if available locally)
Guidelines
-
National Institute for Health and Care Excellence (NICE). Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NG206). 2021. nice.org.uk/guidance/ng206
-
Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. 2015. nap.edu
Key Studies
-
Geraghty K, Jason L, Sunnquist M, et al. The 'cognitive behavioural model' of chronic fatigue syndrome: Critique of a flawed model. Health Psychol Open. 2019;6(1). PMID: 31839997
-
Bateman L, Bested AC, Bonilla HF, et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. Mayo Clin Proc. 2021;96(11):2861-2878. PMID: 34454716
Patient Resources
-
ME Association. meassociation.org.uk
-
Action for ME. actionforme.org.uk
High-Yield Exam Topics
| Topic | Key Points |
|---|---|
| Diagnostic criteria | Fatigue ≥6 months + PEM + Unrefreshing sleep + Cognitive dysfunction |
| Post-exertional malaise | Hallmark feature; delayed symptom worsening after exertion |
| NICE 2021 changes | GET removed; energy management (pacing) is key |
| Investigations | Exclude organic causes; no diagnostic biomarker |
| Management | Pacing, symptom control, MDT support |
| Prognosis | Variable; most remain chronically affected; children better |
Sample Viva Questions
Q1: A 32-year-old presents with 8 months of profound fatigue, cognitive difficulties, and worsening after activity. How do you approach diagnosis?
Model Answer: This presentation is consistent with ME/CFS given symptoms of fatigue, cognitive dysfunction, and the key feature of post-exertional malaise (symptoms worse after activity). ME/CFS is a diagnosis of exclusion. I would take a detailed history including onset (often post-viral), impact on daily life, and enquire specifically about PEM. Examination is usually normal but excludes alternative diagnoses. Investigations: FBC, TFTs, glucose, coeliac serology, CRP, LFTs, U&E — to exclude anaemia, thyroid disease, diabetes, coeliac, inflammation. If investigations are normal and symptoms persist ≥6 months, the diagnosis is ME/CFS. I would explain the diagnosis sensitively and discuss energy management.
Q2: What is post-exertional malaise and why is it important?
Model Answer: Post-exertional malaise (PEM) is a hallmark feature of ME/CFS. It refers to a worsening of symptoms following physical, cognitive, or emotional exertion. Importantly, PEM is delayed — typically occurring 12-72 hours after the activity — and recovery is prolonged. Patients describe "crashes" or "payback." PEM distinguishes ME/CFS from other causes of chronic fatigue (like depression or deconditioning). Its presence is key to diagnosis and informs management — patients must stay within their "energy envelope" to avoid triggering PEM.
Q3: What changed in the NICE 2021 guideline for ME/CFS?
Model Answer: The 2021 NICE guideline (NG206) made significant changes:
- Graded Exercise Therapy (GET) was removed — it is no longer recommended as it can cause harm by triggering PEM.
- Energy management (pacing) is now the central strategy — helping patients identify their limits and stay within them.
- CBT is only offered to help manage the impact of illness, NOT as a cure.
- The Lightning Process is explicitly not recommended.
- The guideline emphasised listening to patients, personalised care, and avoiding harm.
Common Exam Errors
| Error | Correct Approach |
|---|---|
| Recommending graded exercise | GET is no longer recommended (NICE 2021) |
| Saying CBT cures ME/CFS | CBT is adjunctive for coping, NOT curative |
| Missing PEM in history | PEM is the hallmark; always ask about it |
| Extensive investigations | Targeted tests to exclude; there is no diagnostic marker |
| Dismissing symptoms as psychiatric | ME/CFS is a genuine physical illness |
Last Reviewed: 2025-12-24 | MedVellum Editorial Team
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists.